Stock comparison

ABTvsSYK

Abbott LaboratoriesvsStryker Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ABT

Abbott Laboratories

$91.7

-26.39%

Health Care$161.5BNYSE

SYK

Stryker Corp

$329.65

-6.27%

Health Care$125.4BNYSE

60-day price, rebased to 100

ABT -15.89% · SYK -10.80%

Round-by-round

ABT 3·SYK 2· 1tie

EdgeABT

Valuation upside

-14.50% vs -33.60% to DCF fair value

Tie

Balance-sheet strength

Altman Z 4.61 vs 4.61

EdgeABT

Fundamental quality

Piotroski 6.00 vs 5.00 (of 9)

EdgeSYK

Growth + margins

Rule-of-40 22.40 vs 28.20

EdgeSYK

60-day momentum

-15.89% vs -10.80% price return

EdgeABT

Market-cap liquidity

$161.5B vs $125.4B

Verdict

Across6categories,ABTtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onABTorSYK

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.